These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37328863)

  • 1. GAU-PED study for early diagnosis of Gaucher disease in children with splenomegaly and cytopenia.
    Pession A; Di Rocco M; Venturelli F; Tappino B; Morello W; Santoro N; Giordano P; Filippini B; Rinieri S; Russo G; Girardi K; Ruggiero A; Galea E; Antonucci R; Tovaglieri N; Porta F; Tartaglione I; Giona F; Fagioli F; Burlina A;
    Orphanet J Rare Dis; 2023 Jun; 18(1):151. PubMed ID: 37328863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An observational study to investigate the relationship between plasma glucosylsphingosine (lyso-Gb1) concentration and treatment outcomes of patients with Gaucher disease in Japan.
    Ida H; Watanabe Y; Sagara R; Inoue Y; Fernandez J
    Orphanet J Rare Dis; 2022 Nov; 17(1):401. PubMed ID: 36329499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicentre observational study for early diagnosis of Gaucher disease in patients with Splenomegaly and/or Thrombocytopenia.
    Motta I; Filocamo M; Poggiali E; Stroppiano M; Dragani A; Consonni D; Barcellini W; Gaidano G; Facchini L; Specchia G; Cappellini MD;
    Eur J Haematol; 2016 Apr; 96(4):352-9. PubMed ID: 26033455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High risk screening for Gaucher disease in patients with splenomegaly and/or thrombocytopenia in China: 55 cases identified.
    Huang Y; Jia X; Tang C; Liu S; Sheng H; Zhao X; Zeng C; Liu L
    Clin Chim Acta; 2020 Jul; 506():22-27. PubMed ID: 32165122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaucher Disease Diagnosis Using Lyso-Gb1 on Dry Blood Spot Samples: Time to Change the Paradigm?
    Dinur T; Bauer P; Beetz C; Kramp G; Cozma C; Iurașcu MI; Becker-Cohen M; Istaiti M; Rolfs A; Zimran A; Revel-Vilk S
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of glucosylsphingosine in dried blood spots for diagnosis of Gaucher disease by LC-MS/MS.
    Tang C; Jia X; Tang F; Liu S; Jiang X; Zhao X; Sheng H; Peng M; Liu L; Huang Y
    Clin Biochem; 2021 Jan; 87():79-84. PubMed ID: 33188770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the diagnostic utility of the Gaucher Earlier Diagnosis Consensus (GED-C) scoring system using real-world data.
    Revel-Vilk S; Shalev V; Gill A; Paltiel O; Manor O; Tenenbaum A; Azani L; Chodick G
    Orphanet J Rare Dis; 2024 Feb; 19(1):71. PubMed ID: 38365689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaucher Disease for Hematologists.
    Özdemir GN; Gündüz E
    Turk J Haematol; 2022 Jun; 39(2):136-139. PubMed ID: 35439918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Brazilian Rare-Disease Center's Experience with Glucosylsphingosine (lyso-Gb1) in Patients with Gaucher Disease: Exploring a Novel Correlation with IgG Levels in Plasma and a Biomarker Measurement in CSF.
    Vernet Machado Bressan Wilke M; Iop GD; Faqueti L; Lemos da Silva LA; Kubaski F; Poswar FO; Michelin-Tirelli K; Randon D; Borelli WV; Giugliani R; Schwartz IVD
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long- and Short-Term Glucosphingosine (lyso-Gb1) Dynamics in Gaucher Patients Undergoing Enzyme Replacement Therapy.
    Dubiela P; Szymanska-Rozek P; Hasinski P; Lipinski P; Kleinotiene G; Giersz D; Tylki-Szymanska A
    Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062556
    [No Abstract]   [Full Text] [Related]  

  • 11. Glucosylsphingosine (Lyso-Gb1) as a reliable biomarker in Gaucher disease: a narrative review.
    Giuffrida G; Markovic U; Condorelli A; Calafiore V; Nicolosi D; Calagna M; Grasso S; Ragusa MTV; Gentile J; Napolitano M
    Orphanet J Rare Dis; 2023 Feb; 18(1):27. PubMed ID: 36782327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot screening of high-risk Gaucher disease children using dried blood spot methods in Shandong province of China.
    Lei K; Zhao Y; Sun L; Liang H; Luo R; Sun X; Tao Y; Chen L; Zhang L; Li A; Li F; Ding H
    Orphanet J Rare Dis; 2018 Apr; 13(1):48. PubMed ID: 29625627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Misdiagnosis of Gaucher disease in real life: Retrospective study of the French Gaucher's disease registry].
    Perez Y; Belmatoug N; Bengherbia M; Yousfi K; Lioger B
    Rev Med Interne; 2023 Feb; 44(2):55-61. PubMed ID: 36669934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis.
    Kaplan P; Andersson HC; Kacena KA; Yee JD
    Arch Pediatr Adolesc Med; 2006 Jun; 160(6):603-8. PubMed ID: 16754822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Gaucher earlier diagnosis consensus point-scoring system (GED-C PSS): Evaluation of a prototype in Finnish Gaucher disease patients and feasibility of screening retrospective electronic health record data for the recognition of potential undiagnosed patients in Finland.
    Savolainen MJ; Karlsson A; Rohkimainen S; Toppila I; Lassenius MI; Falconi CV; Uusi-Rauva K; Elomaa K
    Mol Genet Metab Rep; 2021 Jun; 27():100725. PubMed ID: 33604241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gaucher disease: A 10 year old girl with anemia and huge spelenomegaly (a case report).
    Davarian A; Mirbehbahani NB
    Pak J Biol Sci; 2008 Apr; 11(7):1063-5. PubMed ID: 18810981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gaucher disease: A review].
    Nguyen Y; Stirnemann J; Belmatoug N
    Rev Med Interne; 2019 May; 40(5):313-322. PubMed ID: 30638965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gaucher disease: A cause of massive splenomegaly in a 15-year-old black African male.
    Ramdin T; Schapkaitz E; Varughese S; Sevitz H
    S Afr Med J; 2022 Feb; 112(1):13515. PubMed ID: 35139999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early diagnosis of Gaucher disease in pediatric patients: proposal for a diagnostic algorithm.
    Di Rocco M; Andria G; Deodato F; Giona F; Micalizzi C; Pession A
    Pediatr Blood Cancer; 2014 Nov; 61(11):1905-9. PubMed ID: 25131373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reductions in glucosylsphingosine (lyso-Gb1) in treatment-naïve and previously treated patients receiving velaglucerase alfa for type 1 Gaucher disease: Data from phase 3 clinical trials.
    Elstein D; Mellgard B; Dinh Q; Lan L; Qiu Y; Cozma C; Eichler S; Böttcher T; Zimran A
    Mol Genet Metab; 2017 Sep; 122(1-2):113-120. PubMed ID: 28851512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.